Bioscience authority awards $4M for medical composite research - Wichita Business Journal:

gault-rickettsias.blogspot.com
It’s part of $21.7 million The Via Christ i Orthopedic Research Institute will receiv e over five years to develolp the Center of Innovation for Biomaterials inOrthopedicd Research. The center could create 2,600 jobs and have a $200 millionm annual economic impact by its10th year, accordingb to a study by ’zs Center for Economic Development and Business The total award is less than the $31 millioj in start-up funds the research institutes sought. Researchers will expand on aviation composites research to develop medical instruments and compositse implants that some say could improves the practiceof orthopedics.
Building the $10 million Centeer of Innovation for Biomaterials in Orthopedif Research is part of an effortr to combine aviationand medicine, two of Wichita’es largest economic drivers. Composites are made by blendin two different metals intoa lighter, strongee part. “It’s an obvious way of diversifying composites and a way to countet the cyclical nature of theaircraft industry,” said Paul Wooley, researcn director at Orthopedic Research, in an Aprik interview with the Wichitwa Business Journal. He wasn’t immediately available for commentg Tuesday.
The research institute hopes to buila 37,000- to 47,000- square-foot facility near the National Center for Aviatiojn Training at Col. James Jabara Airport. The KBA moneg would not includeconstruction costs, which likely wouldf be funded through bonds. Orthopedic Researchj is working with onthe project. Partnere in the project includeVia Christi, WSU and its , and . The KBA also approvec three other investmentson Tuesday. They are: • $4 million for the to create medicalp instruments, medical devices and composite implants. The cente r is expected to increase employment in Kansa sby 2,000 during 10 years. $1.
9 million for the developmentt ofcancer drugs, including $195,000 for Lenexa-based to commercializr reformulated drugs that address limitations of existingg therapies. A focus will be on improvinfg a cancer drug for patients withmultiple myeloma, cancer of the plasma B cells formedr in the bone marrow. • $1.2 milliob for bioenergy research at the as a matchto $1.2 milliom invested by Research will focus on converting multipled feedstocks, including biomass, into fuels and chemicals to replacew or improve on petroleum-based The university will provide in-kindr support valued at more than